Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BPIFA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BGLT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HIKESHI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP65 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RWDD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506207 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYOG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNUPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCA1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHYHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505685 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEA9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPH5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on